Cases 11 - 20 of 26
United HealthCare Services, Inc. v. Merck & Co., Inc. et al
as 0:2020cv01909
Defendant:
MSP Singapore Company LLC, Merck & Co., Inc., Glenmark Pharmaceuticals Inc., USA and others
Plaintiff:
United HealthCare Services, Inc.
Cause Of Action: 15 U.S.C. § 1
Astellas US LLC et al v. Glenmark Pharmaceuticals Limited
as 1:2020cv00516
Plaintiff:
Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc.
Defendant:
Glenmark Pharmaceuticals Limited
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Apotex Inc. et al
as 1:2020cv00133
Defendant:
Bionpharma Inc., Strides Pharma, Inc., Prinston Pharmaceutical Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1
BAUSCH HEALTH IRELAND LIMITED et al v. GLENMARK PHARMACEUTICALS LIMITED
as 3:2019cv14502
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and BAUSCH HEALTH AMERICAS INC.
Defendant:
GLENMARK PHARMACEUTICALS LIMITED
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Glenmark Pharmaceuticals Limited et al
as 1:2019cv01209
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA
Cause Of Action: 35 U.S.C. § 271
Eisai Co., Ltd. et al v. Glenmark Pharmaceuticals Limited et al
as 1:2019cv01214
Plaintiff:
Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant:
Glenmark Pharmaceuticals Limited, Glenmark Pharmaceuticals Inc., USA and Glenmark Generics Limited
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. GLENMARK PHARMACEUTICALS LIMITED
as 1:2019cv12045
Plaintiff:
ASSERTIO THERAPEUTICS INC. and BAUSCH HEALTH IRELAND LIMITED
Defendant:
GLENMARK PHARMACEUTICALS LIMITED
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2018cv00460
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2017cv01653
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
